Chemokines and Chemokine Receptors: Potential Therapeutic Targets in Multiple Sclerosis

Current Drug Target -Inflammation & Allergy
doi 10.2174/1568010043343732
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Chemokine Receptors as Therapeutic Targets

Japanese Journal of Clinical Immunology
2013English

Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy

Frontiers in Immunology
AllergyImmunology
2019English

G Protein-Coupled Receptors as Therapeutic Targets for Multiple Sclerosis

Cell Research
Cell BiologyMolecular Biology
2012English

Expression of Specific Chemokines and Chemokine Receptors in the Central Nervous System of Multiple Sclerosis Patients

Journal of Clinical Investigation
Medicine
1999English

Chemokines in Chronic Liver Allograft Dysfunction Pathogenesis and Potential Therapeutic Targets

Clinical and Developmental Immunology
2013English

EphrinB3 and EphrinB4 Receptors Are Potential Therapeutic Targets in Glioblastoma

Canadian Journal of Neurological Sciences
MedicineNeurology
2015English

Sigma Receptors as Potential Therapeutic Targets for Neuroprotection

European Journal of Pharmacology
Pharmacology
2014English

Liver X Receptors as Potential Therapeutic Targets in Atherosclerosis

Clinical and Investigative Medicine
Medicine
2009English

Identification of ncRNAs as Potential Therapeutic Targets in Multiple Sclerosis Through Differential ncRNA – mRNA Network Analysis

BMC Genomics
BiotechnologyGenetics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy